Concepedia

Patrick Fagan

PF

11

Publications

718

Citations

11

H-Index

2004

Active since

Affiliations

Biota Pharmaceuticals (United States)(Current)

Cornell University

Memorial Sloan Kettering Cancer Center

Patrick Fagan is an author at Biota Pharmaceuticals (United States) specializing in medicine, drug discovery, and hiv.

Top concepts

Publications per year

2004–2019

11

Publications

11

A novel, orally active LPA <sub>1</sub> receptor antagonist inhibits lung fibrosis in the mouse bleomycin model

J. S. Swaney, Charles W. Chapman, LD Correa et al. · British Journal of Pharmacology · 2010 · 257 citations · Full text

RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells

Mark A. Hawk, Cassandra L. Gorsuch, Patrick Fagan et al. · Nature Cell Biology · 2018 · 95 citations · Full text

, , +9

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor

Yumi Yokoyama, Erin D. Lew, Ruth Seelige et al. · Cancer Research · 2019 · 80 citations

Synthesis of AZT 5‘-Triphosphate Mimics and Their Inhibitory Effects on HIV-1 Reverse Transcriptase

Guangyi Wang, Nicholas Boyle, Chen Fu et al. · Journal of Medicinal Chemistry · 2004 · 59 citations

, , +18

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

Karin J. Stebbins, Alex Broadhead, Christopher Baccei et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 48 citations

Rows per page

1–5 of 11